Italian Journal of Dermatology and Venereology最新文献

{"title":"Belimumab as a potential therapeutic option for bullous systemic lupus erythematosus.","authors":"Carolina Donelli, Cristiana Barreca, Laura Calabrese, Pietro Rubegni, Laura Lazzeri","doi":"10.23736/S2784-8671.24.08057-5","DOIUrl":"10.23736/S2784-8671.24.08057-5","url":null,"abstract":"","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":"182-183"},"PeriodicalIF":1.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143005388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efficacy and safety of treatment with biological drugs in psoriasis patients with a history of malignancies: a single-center observational study.","authors":"Edoardo Mortato, Giorgia Sbarra, Riccardo Viola, Alexandre R Meduri, Felice Primavera, Francesco Loconsole","doi":"10.23736/S2784-8671.25.08035-1","DOIUrl":"10.23736/S2784-8671.25.08035-1","url":null,"abstract":"","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":"181-182"},"PeriodicalIF":1.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143046519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"IgA pemphigus following SARS-Cov-2 vaccine.","authors":"Eleonora DI Michele, Andrea DI Buduo, Italo F Aromolo, Michele Parietti, Elisa Robustelli Test, Angelo V Marzano, Paolo Sena, Pamela Vezzoli","doi":"10.23736/S2784-8671.25.07995-2","DOIUrl":"https://doi.org/10.23736/S2784-8671.25.07995-2","url":null,"abstract":"","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":"160 2","pages":"176-177"},"PeriodicalIF":1.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144003312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dermoscopic and trichoscopic features of follicular mycosis fungoides: a systematic review.","authors":"Mikela Petkovic, Romana Ceovic, Daniela Ledic Drvar, Jaka Rados, Ruzica Jurakic Toncic","doi":"10.23736/S2784-8671.25.07794-1","DOIUrl":"https://doi.org/10.23736/S2784-8671.25.07794-1","url":null,"abstract":"<p><strong>Introduction: </strong>Folliculotropic mycosis fungoides (FMF) is a distinctive variant of mycosis fungoides (MF). FMF has worse clinical outcome when compared to the MF and commonly used skin-based therapy may be refractory. The aim of this study is to give a systematic review of dermoscopic and trichoscopic findings in FMF and to summarize current knowledge on usefulness of dermoscopy in patients with FMF.</p><p><strong>Evidence acquisition: </strong>A search of the literature was performed using the electronic database PubMed by selecting the words \"dermoscopy,\" \"dermatoscopy,\" \"trichoscopy,\" and \"follicular mycosis fungoides.\"</p><p><strong>Evidence synthesis: </strong>After exclusion criteria, 10 articles in total were included in this review. Among 10 selected articles, a total number of 59 patients were included, and total of 23 dermoscopic features were described. Only seven of 23 dermoscopic features were present in over half of the patients (over 30 in total number of 59 patients). Among obtained results, only five dermoscopic features were found in more than 70% of the patients; but none of these were described in majority of the patients. Among these published papers, the dermoscopic features of cutaneous lymphomas were correlated with the histopathology.</p><p><strong>Conclusions: </strong>After reviewing all these papers we can conclude that dermoscopic features related to the pathology found in follicle, although characteristic, are not pathognomonic when it comes to diagnosing FMF. A finding of multiple characteristic dermoscopic features is required to indicate a diagnosis of FMF but in the corresponding clinical context. In some cases, dermoscopy can be used as a useful tool for determining optimal biopsy site with the potential of increasing specificity of pathohistological diagnosis which is crucial because of choice of the therapeutic approach having in mind that FMF is more refractory to the conventional treatment of MF.</p>","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":"160 2","pages":"165-171"},"PeriodicalIF":1.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144024155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Erythema multiforme major presenting in a teenager with anti-N-Methyl-D-Aspartate receptor encephalitis.","authors":"Valentina Caputo, Emanuela Bonoldi, Jan Schroeder, Franco Rongioletti","doi":"10.23736/S2784-8671.25.08074-0","DOIUrl":"10.23736/S2784-8671.25.08074-0","url":null,"abstract":"","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":"187-189"},"PeriodicalIF":1.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143567114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Current landscape and future perspectives in the pathogenesis and treatment of Pyoderma gangrenosum.","authors":"Sarah L Becker, Alex G Ortega-Loayza","doi":"10.23736/S2784-8671.24.08010-1","DOIUrl":"10.23736/S2784-8671.24.08010-1","url":null,"abstract":"<p><p>Pyoderma gangrenosum is a rare, ulcerative neutrophilic dermatosis of yet unknown origin. While advances have been made into the mechanisms underlying PG, our understanding is limited by a paucity of research and funding into this condition. This review highlights the current landscape of PG pathogenesis, diagnosis, and treatment in the hopes of encouraging additional scientific inquiry into this rare, severe condition.</p>","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":"145-154"},"PeriodicalIF":1.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142750815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Methotrexate and 5-fluorouracil for refractory squamous cell carcinomas in epidermodysplasia verruciformis unresponsive to conventional therapies.","authors":"Gaetano Licata, Caterina M Giorgio, Dario Buononato, Nicola M Giorgio, Eugenia V DI Brizzi, Giuseppe Argenziano","doi":"10.23736/S2784-8671.25.08120-4","DOIUrl":"https://doi.org/10.23736/S2784-8671.25.08120-4","url":null,"abstract":"","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":"160 2","pages":"189-190"},"PeriodicalIF":1.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144003606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Guselkumab: a safe treatment option for patients with comorbid psoriasis and multiple sclerosis.","authors":"Chang-Yu Hsieh, Tsen-Fang Tsai","doi":"10.23736/S2784-8671.25.08167-8","DOIUrl":"https://doi.org/10.23736/S2784-8671.25.08167-8","url":null,"abstract":"","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":"160 2","pages":"192-193"},"PeriodicalIF":1.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143996304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efficacy and safety of risankizumab for the treatment of patients with plaque type psoriasis.","authors":"Fan Lin, Tsen-Fang Tsai","doi":"10.23736/S2784-8671.24.07996-9","DOIUrl":"10.23736/S2784-8671.24.07996-9","url":null,"abstract":"<p><p>Risankizumab (Skyrizi^®, Abbvie, North Chicago, IL, USA) is a humanized immunoglobulin (Ig) G1 monoclonal antibody targeting the p19 subunit of IL-23, thereby inhibiting IL-23-dependent releasing of proinflammatory cytokines in plaque psoriasis. Risankizumab is licensed is most countries for the treatment of patients with moderate-to-severe plaque psoriasis, and in Japan for generalized pustular psoriasis, erythrodermic psoriasis and palmoplantar pustulosis. Risankizumab showed higher efficacy and favorable safety profiles in patients with moderate-to-severe plaque psoriasis, compared with adalimumab, secukinumab and ustekinumab in several randomized controlled phase 3 pivotal studies and among real-life data in large retrospective studies. Furthermore, its high efficacy even in patients with prior biologic failure, better drug survival, less need for biologic switch and longer drug-free remission durations have also been shown in real-life settings and in long-term follow-up. In addition, reports of both reduced dosing and increased (bolus) dosing exist which increase our ability to use risankizumab more flexibly in an era of personalized medicine. Also, the use of risankizumab in several special population, such as elderly, Asian people, erythrodermic psoriasis, patients with high induction doses, pregnancy and human immunodeficiency virus group are discussed.</p>","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":"155-164"},"PeriodicalIF":1.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143065560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Treating psoriatic arthritis in the early phase: proposal for a shared dermatological and rheumatological therapeutic intervention with biologics and targets synthetic disease-modifying immunosuppressive drugs.","authors":"Andrea Picchianti Diamanti, Marco Galluzzo, Annunziata Dattola, Arianna D'Antonio, Augusta Ortolan, Domenico Giordano, Magda D'Agostino, Rossana Scrivo","doi":"10.23736/S2784-8671.24.07927-1","DOIUrl":"10.23736/S2784-8671.24.07927-1","url":null,"abstract":"","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":"173-175"},"PeriodicalIF":1.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143407810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}